Property, Rights, and the constitution of contemporary Indian biomedicine: Notes from the Gleevec case
September 24 2012
Seminar Room 1.06, Old Surgeons' Hall, High School Yards, University of Edinburgh, EH1 1LZ
All welcome, no need to register
Organised by: Innogen at the University of Edinburgh
In this paper, I am interested in tracing how intellectual property regimes drive the re-institutionalization of pharmaceutical development in India today in unsettled and contested ways. I draw upon an exemplary case surrounding a patent on the anti-cancer drug Gleevec. I am interested in how this case resolves, in an apparent purification, into technical and constitutional components; how the technical components are entirely unsettled; and how the constitutional components open up questions regarding the relationship between biocapital and issues of constitutionalism, rights, and corporate social responsibility.
Kaushik Sunder Rajan is an Associate Professor at the University of Chicago, where he studies the anthropology of science, technology, and medicine. His work has focused on a number of interrelated events and emergences: firstly, the increased corporatization of life science research; secondly, the emergence of new technologies and epistemologies within the life sciences, such as, significantly, genomics; and thirdly, the fact that these technoscientific and market emergences were not simply occurring in the United States, but rather globally.